Advil liqui-gels and Infusion site haematoma - a phase IV clinical study of FDA data

Summary:

Infusion site haematoma is reported only by a few people who take Advil Liqui-Gels.

The phase IV clinical study analyzes which people take Advil liqui-gels and have Infusion site haematoma. It is created by eHealthMe based on reports of 4,733 people who have side effects while taking Advil liqui-gels from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 18, 2023

4,733 people reported to have side effects when taking Advil liqui-gels.
Among them, 2 people (0.04%) have Infusion site haematoma.

What is Advil liqui-gels?

Advil liqui-gels has active ingredients of ibuprofen. It is often used in headache. eHealthMe is studying from 4,936 Advil liqui-gels users for its effectiveness, alternative drugs and more.

What is Infusion site haematoma?

Infusion site haematoma (localized swelling filled with blood at infusion site) is found to be associated with 259 drugs and 123 conditions by eHealthMe.

Number of Advil liqui-gels and Infusion site haematoma reports submitted per year:

Could Advil liqui-gels cause Infusion site haematoma?

Gender of people who have Infusion site haematoma when taking Advil liqui-gels *:

female: 100 %
male: 0.0 %

Age of people who have Infusion site haematoma when taking Advil liqui-gels *:

Common drugs people take besides Advil liqui-gels *:

Naproxen: 2 people, 100.00%
Metoclopramide: 2 people, 100.00%

Common side effects people have besides Infusion site haematoma *:

Viral Infection: 2 people, 100.00%
Infusion Site Pain: 2 people, 100.00%
Infusion Site Erythema (reddening of the skin at infusion site): 2 people, 100.00%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 100.00%
Tonsillitis (inflammation of tonsil): 1 person, 50.00%
Tongue Disorder (disease of tongue): 1 person, 50.00%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 50.00%
Muscle Spasms (muscle contraction): 1 person, 50.00%
Movement - Uncontrolled Or Slow: 1 person, 50.00%
Joint Stiffness: 1 person, 50.00%

Common conditions people have *:

Depression: 2 people, 100.00%
Viral Infection: 1 person, 50.00%
Nausea And Vomiting: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Advil liqui-gels and have Infusion site haematoma?

Check whether Infusion site haematoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .

Related studies

Browse all side effects of Advil liqui-gels:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Infusion site haematoma treatments and more:

Infusion site haematoma (422 reports)

COVID vaccines that are related to Infusion site haematoma:

Common drugs associated with Infusion site haematoma:

Tysabri: 213 reports

All the drugs that are associated with Infusion site haematoma:

Infusion site haematoma (259 drugs)

Common conditions associated with Infusion site haematoma:

Multiple sclerosis: 220 reports

All the conditions that are associated with Infusion site haematoma:

Infusion site haematoma (123 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Advil liqui-gels) and Advil liqui-gels (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.